Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Neamati

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|February 3, 1998
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell linesU Consoli, N T Van, N Neamati, et al.
International Journal of Oncology|June 15, 2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cellsC Plasencia, E Martínez-Balibrea, A Martinez-Cardús, et al.
Molecular Pharmacology|August 4, 1998
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integraseN Neamati, A Mazumder, S Sunder, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitorsN Neamati, A Mazumder, H Zhao, et al.
Molecular Pharmacology|April 1, 1996
Effects of nucleotide analogues on human immunodeficiency virus type 1 integraseA Mazumder, N Neamati, J P Sommadossi, et al.
Antiviral Chemistry & Chemotherapy|December 29, 1998
Identification of HIV-1 integrase inhibitors based on a four-point pharmacophoreH Hong, N Neamati, H E Winslow, et al.
Journal of Medicinal Chemistry|March 14, 1997
Hydrazide-containing inhibitors of HIV-1 integraseH Zhao, N Neamati, S Sunder, et al.
Journal of Medicinal Chemistry|March 14, 1997
HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searchingM C Nicklaus, N Neamati, H Hong, et al.
European Journal of Medicinal Chemistry|June 20, 2006
An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integraseF Aiello, A Brizzi, O De Grazia, et al.
International Journal of Cancer|March 28, 1997
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposideR Perez-Soler, N Neamati, Y Zou, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|February 3, 1998
Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell linesU Consoli, N T Van, N Neamati, et al.
International Journal of Oncology|June 15, 2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cellsC Plasencia, E Martínez-Balibrea, A Martinez-Cardús, et al.
Molecular Pharmacology|August 4, 1998
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integraseN Neamati, A Mazumder, S Sunder, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitorsN Neamati, A Mazumder, H Zhao, et al.
Molecular Pharmacology|April 1, 1996
Effects of nucleotide analogues on human immunodeficiency virus type 1 integraseA Mazumder, N Neamati, J P Sommadossi, et al.
Antiviral Chemistry & Chemotherapy|December 29, 1998
Identification of HIV-1 integrase inhibitors based on a four-point pharmacophoreH Hong, N Neamati, H E Winslow, et al.
Journal of Medicinal Chemistry|March 14, 1997
Hydrazide-containing inhibitors of HIV-1 integraseH Zhao, N Neamati, S Sunder, et al.
Journal of Medicinal Chemistry|March 14, 1997
HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searchingM C Nicklaus, N Neamati, H Hong, et al.
European Journal of Medicinal Chemistry|June 20, 2006
An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integraseF Aiello, A Brizzi, O De Grazia, et al.
International Journal of Cancer|March 28, 1997
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposideR Perez-Soler, N Neamati, Y Zou, et al.
Pageof 5